Novartis MS Drug Kesimpta Quick Out Of The Blocks
Strong Challenger To Roche's Ocrevus
Kesimpta is a treatment option for multiple sclerosis patients "that doesn't need compromise, the trade-off between high efficacy and high treatment burden," Novartis neuroscience chief Norman Putzki tells Scrip.
